Treatment of arsenical keratosis with etretinate.
Treatment with oral etretinate is reported in a case of arsenical keratosis with Bowen's disease. Good (80%) clearance in keratoses was obtained, which is maintained after 15 months' follow up.
D000284:Administration, Oral; D000368:Aged; D001152:Arsenicals / Q000009:adverse effects* / Q000627:therapeutic use; D005050:Etretinate / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007642:Keratosis / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy
D001152:Arsenicals; D005050:Etretinate